These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28769760)

  • 1. Implications of DNA Methylation in Parkinson's Disease.
    Miranda-Morales E; Meier K; Sandoval-Carrillo A; Salas-Pacheco J; Vázquez-Cárdenas P; Arias-Carrión O
    Front Mol Neurosci; 2017; 10():225. PubMed ID: 28769760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in Parkinson's disease.
    Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
    J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in Parkinson's Disease.
    Pavlou MAS; Outeiro TF
    Adv Exp Med Biol; 2017; 978():363-390. PubMed ID: 28523556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes.
    Masliah E; Dumaop W; Galasko D; Desplats P
    Epigenetics; 2013 Oct; 8(10):1030-8. PubMed ID: 23907097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.
    Angelopoulou E; Paudel YN; Papageorgiou SG; Piperi C
    Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modification in Parkinson's disease.
    Song H; Chen J; Huang J; Sun P; Liu Y; Xu L; Wei C; Mu X; Lu X; Wang W; Zhang N; Shang M; Mo M; Zhang W; Zhao H; Han F
    Front Cell Dev Biol; 2023; 11():1123621. PubMed ID: 37351278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenome-Wide Analysis of DNA Methylation in Parkinson's Disease Cortex.
    Kaut O; Schmitt I; Stahl F; Fröhlich H; Hoffmann P; Gonzalez FJ; Wüllner U
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
    Kaut O; Kuchelmeister K; Moehl C; Wüllner U
    J Chem Neuroanat; 2019 Mar; 96():41-48. PubMed ID: 30557654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.
    Yazar V; Dawson VL; Dawson TM; Kang SU
    J Parkinsons Dis; 2023; 13(2):145-164. PubMed ID: 36710687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson's Disease.
    Dashtipour K; Tafreshi A; Adler C; Beach T; Chen X; Serrano G; Tashiro S; Wang C
    Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28653979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood.
    Henderson-Smith A; Fisch KM; Hua J; Liu G; Ricciardelli E; Jepsen K; Huentelman M; Stalberg G; Edland SD; Scherzer CR; Dunckley T; Desplats P
    Epigenetics; 2019 Apr; 14(4):365-382. PubMed ID: 30871403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
    Jakubowski JL; Labrie V
    J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epigenetics in Alzheimer's and Parkinson's disease.
    Kwok JB
    Epigenomics; 2010 Oct; 2(5):671-82. PubMed ID: 22122050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease-associated shifts between DNA methylation and DNA hydroxymethylation in human brain in PD-related genes, including PARK19 (DNAJC6) and PTPRN2 (IA-2β).
    Choza JI; Virani M; Kuhn NC; Adams M; Kochmanski J; Bernstein AI
    Res Sq; 2024 Jul; ():. PubMed ID: 39070644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation as a mediator of genetic and environmental influences on Parkinson's disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome.
    Schaffner SL; Kobor MS
    Front Genet; 2022; 13():971298. PubMed ID: 36061205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
    Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
    Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms.
    Murray LK; Jadavji NM
    Nutr Res Rev; 2019 Dec; 32(2):218-230. PubMed ID: 31303188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
    Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U
    Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation in Parkinson's disease.
    Labbé C; Lorenzo-Betancor O; Ross OA
    Acta Neuropathol; 2016 Oct; 132(4):515-30. PubMed ID: 27358065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.